Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns

Infection and Immunity

Volumn 79, Issue 7, 2011, Pages 2690-2698

  Giannoni, Eric ^a   Guignard, Laurence ^a   Reymond, Marlies Knaup ^a   Perreau, Matthieu ^a   Roth Kleiner, Matthias ^a   Calandra, Thierry ^a   Roger, Thierry ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOID DIFFERENTIATION FACTOR 88; NORGESTREL; PROGESTERONE; PROGESTERONE RECEPTOR; STEROID RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFECTION SENSITIVITY; INNATE IMMUNITY; MALE; MONOCYTE; NEWBORN; NEWBORN PERIOD; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

ADULT; BLOTTING, WESTERN; CELLS, CULTURED; CYTOKINES; ENDOTOXINS; ESCHERICHIA COLI; ESTRADIOL; FEMALE; FETAL BLOOD; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; LIPOPEPTIDES; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; POLYMERASE CHAIN REACTION; PROGESTERONE; RECEPTORS, STEROID; STREPTOCOCCUS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 79959456894     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00076-11     Document Type: Article

References (47)

1. Adkins, B., C. Leclerc, and S. Marshall-Clarke. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553-564.
2. An, J., et al. 1999. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc. Natl. Acad. Sci. U. S. A. 96:15161-15166.
3. Asai, K., et al. 2001. Gender differences in cytokine secretion by humanperipheral blood mononuclear cells: role of estrogen in modulating LPSinduced cytokine secretion in an ex vivo septic model. Shock 16:340-343.
4. Bessler, H., et al. 1999. Effects of dexamethasone on IL-1beta, IL-6, and TNF-alpha production by mononuclear cells of newborns and adults. Biol. Neonate 75:225-233.
5. Bromberger, P., et al. 2000. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 106:244-250.
6. Calippe, B., et al. 2010. 17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo. J. Immunol. 185:1169-1176.
7. Carruba, G., et al. 2003. Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. J. Cell. Biochem. 90:187-196.
8. Dawood, M. Y., and F. Helmkamp. 1977. Human umbilical arterial and venous progesterone concentrations: effect of fetal sex, weight, and mode of delivery. Obstet. Gynecol. 50:450-453.
9. Galon, J., et al. 2002. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16:61-71.
10. Gellersen, B., M. S. Fernandes, and J. J. Brosens. 2009. Non-genomic progesterone actions in female reproduction. Hum. Reprod. Update 15:119- 138.
11. Gotsch, F., et al. 2007. The fetal inflammatory response syndrome. Clin. Obstet. Gynecol. 50:652-683.
12. Hughes, I. A., D. Riad-Fahmy, and K. Griffiths. 1979. Plasma 17OH-progesterone concentrations in newborn infants. Arch. Dis. Child. 54:347-349.
13. Hunt, J. S., et al. 1997. Female steroid hormones regulate production of pro-inflammatory molecules in uterine leukocytes. J. Reprod. Immunol. 35: 87-99.
14. Hyde, T. B., et al. 2002. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 110:690-695.
15. Imasato, A., et al. 2002. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of Toll-like receptor 2. J. Biol. Chem. 277: 47444-47450.
16. Karteris, E., et al. 2006. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol. Endocrinol. 20:1519-1534.
17. Kenny, F. M., K. Angsusingha, D. Stinson, and J. Hotchkiss. 1973. Unconjugated estrogens in the perinatal period. Pediatr. Res. 7:826-831.
18. Kontula, K., T. Paavonen, T. Luukkainen, and L. C. Andersson. 1983. Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem. Pharmacol. 32:1511-1518.
19. Levy, O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7:379-390.
20. Li, X., D. M. Lonard, and B. W. O'Malley. 2004. A contemporary understanding of progesterone receptor function. Mech. Ageing Dev. 125:669-678.
21. Miller, L., and J. S. Hunt. 1998. Regulation of TNF-alpha production in activated mouse macrophages by progesterone. J. Immunol. 160:5098-5104.
22. Nagata, C., S. Iwasa, M. Shiraki, Y. Sahashi, and H. Shimizu. 2007. Association of maternal fat and alcohol intake with maternal and umbilical hormone levels and birth weight. Cancer Sci. 98:869-873.
23. Peluso, J. J. 2003. Progesterone as a regulator of granulosa cell viability. J. Steroid Biochem. Mol. Biol. 85:167-173.
24. Persson, E., B. Trollfors, L. L. Brandberg, and I. Tessin. 2002. Septicaemia and meningitis in neonates and during early infancy in the Goteborg area of Sweden. Acta Paediatr. 91:1087-1092.
25. Remington, J. S., J. O. Klein, C. Baker, and C. B. Wilson (ed.). 2006. Infectious diseases of the fetus and the newborn infant, 6th ed. Elsevier, Philadelphia, PA.
26. Roger, T., A. L. Chanson, M. Knaup-Reymond, and T. Calandra. 2005.Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur. J. Immunol. 35:3405-3413.
27. Roger, T., J. David, M. P. Glauser, and T. Calandra. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414:920-924.
28. Roger, T., et al. 2009. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Natl. Acad. Sci. U. S. A. 106:2348- 2352.
29. Roger, T., et al. 2010. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117:1205- 1217.
30. Roger, T., et al. 2005. Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression. Biochem. J. 387:355-365.
31. Roger, T., et al. 1998. Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells. Biochem. J. 330(Pt 1):429-435.
32. Sadeghi, K., et al. 2007. Immaturity of infection control in preterm and term newborns is associated with impaired Toll-like receptor signaling. J. Infect. Dis. 195:296-302.
33. Schust, D. J., D. J. Anderson, and J. A. Hill. 1996. Progesterone-induced immunosuppression is not mediated through the progesterone receptor. Hum. Reprod. 11:980-985.
34. Schwartz, N., X. Xue, M. A. Elovitz, O. Dowling, and C. N. Metz. 2009. Progesterone suppresses the fetal inflammatory response ex vivo. Am. J. Obstet. Gynecol. 201:e211-e219.
35. Shuto, T., et al. 2002. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J. Biol. Chem. 277:17263-17270.
36. Siegrist, C. A., and R. Aspinall. 2009. B-cell responses to vaccination at the extremes of age. Nat. Rev. Immunol. 9:185-194.
37. Srivastava, S., et al. 1999. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J. Clin. Invest. 104:503-513.
38. Straub, R. H. 2007. The complex role of estrogens in inflammation. Endocr. Rev. 28:521-574.
39. Suzuki, T., et al. 2007. Estrogen receptor-alpha predominantly mediates the salutary effects of 17beta-estradiol on splenic macrophages following trauma-hemorrhage. Am. J. Physiol. Cell. Physiol. 293:C978-C984.
40. Thomas, P. 2008. Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front. Neuroendocrinol. 29:292-312.
41. Troisi, R., et al. 2003. Estrogen and androgen concentrations are not lower in the umbilical cord serum of pre-eclamptic pregnancies. Cancer Epidemiol. Biomarkers Prev. 12:1268-1270.
42. Trotter, A., et al. 1999. Effects of postnatal estradiol and progesterone replacement in extremely preterm infants. J. Clin. Endocrinol. Metab. 84: 4531-4535.
43. Trotter, A., L. Maier, M. Kron, and F. Pohlandt. 2007. Effect of oestradiol and progesterone replacement on bronchopulmonary dysplasia in extremely preterm infants. Arch. Dis. Child. Fetal Neonatal ed. 92:F94-F98.
44. Webster, J. I., L. Tonelli, and E. M. Sternberg. 2002. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20:125-163.
45. Yan, S. R., et al. 2004. Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect. Immun. 72:1223-1229.
46. Yerkovich, S. T., et al. 2007. Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr. Res. 62:547-552.
47. Yuan, Y., et al. 2008. Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C. World J. Gastroenterol. 14:2200-2207.